Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: My 2 cents on the R/S discussion

With that in mind, he has discussed the R/S issue in the framework that PTSC will use it to GAIN a listing on a better exchange because aside from PPS, their fundamentals support that. That's a far cry from having to do it MAINTAIN a listing on their current exchange because their fundamentals are failing, like most companies who R/S seem to be faced with. It's this latter situation which usually ultimatley doesn't work longterm, that creates the negative stigma. I think the PTSC situation is NOT that, so the R/S has a very good chance of working if the other aspects are in place, in my opinion.

This begs to differ.

It would look the same from $6 as it does from $0.60. Perhaps worse.









Share
New Message
Please login to post a reply